|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net earnings (loss) | |||||
| Discontinued operations, net of tax | |||||
| Adjustments for non-cash items, net: | |||||
| Depreciation and amortization | |||||
| Deferred income tax provision | |||||
| Stock-based compensation cost | |||||
| Equity method investment net earnings | |||||
| Impairment charge on minority-owned joint venture investments | |||||
| (Gain) loss on extinguishment of debt | |||||
| (Gain) loss on sale of investments / deconsolidation | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable, net | |||||
| Contract assets, current | |||||
| Inventories, net | |||||
| Other assets, current | |||||
| Accounts payable and accrued liabilities | |||||
| Contract liabilities, current | |||||
| Defined benefit plan contributions | |||||
| Distributions from equity method investments | |||||
| Other operating activities, net | |||||
| Net cash flows provided by (used in) continuing operating activities | |||||
| Net cash flows provided by (used in) discontinued operating activities | |||||
| Net cash flows provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Proceeds on sale of investments | |||||
| Investment in businesses, net of cash acquired | |||||
| Dispositions of businesses | |||||
| Settlement of derivative contracts, net | |||||
| Payment to former shareholders of TCC | |||||
| Other investing activities, net | |||||
| Net cash flows provided by (used in) continuing investing activities | |||||
| Net cash flows provided by (used in) discontinued investing activities | |||||
| Net cash flows provided by (used in) investing activities | |||||
| Financing Activities | |||||
| (Decrease) increase in short-term borrowings, net | |||||
| Issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Repurchases of common stock | |||||
| Dividends paid on common stock | |||||
| Dividends paid to non-controlling interest | |||||
| Other financing activities, net | |||||
| Net cash flows provided by (used in) continuing financing activities | |||||
| Net cash flows provided by (used in) discontinued financing activities | |||||
| Net cash flows provided by (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash, including cash classified in current assets held for sale | |||||
| Less: Change in cash balances classified as assets held for sale | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Less: restricted cash | |||||
| Cash and cash equivalents, end of period |
Loading...